This session, designed for the fellows, clinician educator and program director focuses on designing and delivering curricula for GI fellows on the topics of nutrition, including the obesity epidemic…
This session, designed for the fellows, clinician educator and program director focuses on designing and delivering curricula for GI fellows on the topics of nutrition, including the obesity epidemic…
BACKGROUND: Malnutrition is a complication of Roux-en-Y gastric bypass (RYGB) and can range from micronutrient deficiencies to protein-calorie malnutrition. Malignant neoplasms and certain surgical complications can increase this risk…
Basil I. Hirschowitz Endoscopic Center of Excellence, Division of Gastroenterology & Hepatology, Department of Internal Medicine, The University of Alabama at Birmingham Heersink School of Medicine
BACKGROUND: Malnutrition is a complication of Roux-en-Y gastric bypass (RYGB) and can range from micronutrient deficiencies to protein-calorie malnutrition. Malignant neoplasms and certain surgical complications can increase this risk…
BACKGROUND: To address the persistent ethnoracial and socioeconomic disparities in access to quality surgical cancer care, it is imperative to rigorously understand the role of clinician-level factors including clinician-to-clinician connectedness…
Laparoscopic fundoplication in patients with a history of lung transplant has an average length of stay (LOS) of 3 days with a 30-day readmission rate of 25%, which is significantly worse compared to the non-lung transplant population…
Laparoscopic fundoplication in patients with a history of lung transplant has an average length of stay (LOS) of 3 days with a 30-day readmission rate of 25%, which is significantly worse compared to the non-lung transplant population…
Laparoscopic fundoplication in patients with a history of lung transplant has an average length of stay (LOS) of 3 days with a 30-day readmission rate of 25%, which is significantly worse compared to the non-lung transplant population…
Background: Transoral outlet reduction endoscopy (TORe) has been shown to be effective in managing weight regain after Roux-en-Y gastric bypass (RYGB), as has the glucagon-like peptide-1 agonist, liraglutide. However, the effect of adjunctive liraglutide after TORe has yet to be assessed…
Background: Current non-invasive tests (NITs) utilized to screen and predict liver fibrosis were developed in predominantly Caucasian populations, and their performance in non-Caucasians is not well known…
Background: Gastric sleeve stenosis (GSS) is an increasingly common adverse event following sleeve gastrectomy (SG) and thought to result from progressive rotation and/or scarring of the sleeve. Objective diagnostic criteria for this condition are lacking…
Endoscopic ultrasound-guided gastroejejunostomy (EUS-GJ) has gained popularity in treating malignant gastric outlet obstruction (GOO). EUS-GJ has also been used to manage benign GOO with promising technical and clinical success…
BACKGROUND: Hepatic encephalopathy (HE) is associated with increased mortality, falls, and frequent hospitalizations. Patient reported outcomes (PROs) are useful tools to assess health-related quality of life (HRQOL) measures such as impairment of sleep, cognition, or activity…
BACKGROUND: Despite the advances in the multidisciplinary treatment of gastric adenocarcinoma, the overall 5-year survival remains only 33.3% in North America. R0 resection with adequate lymphadenectomy remains the mainstay therapy…
Background: Endoscopic Bariatric Therapy has emerged as an alternative minimally invasive treatment for patients with obesity. Endoscopic Sleeve Gastroplasty (ESG) can provide good weight loss outcomes with a low adverse event rate…
INTRODUCTION: Artificial Intelligence (AI) large language models (LLMs) show promise in medicine, however general-purpose AI models underperform on clinical tasks. Recognizing this potential, our team developed a specialty-specific multi-task clinical LLM: GastroGPT (Fig 1)…
INTRODUCTION: Most endoscopists perform ERCP with only a side-viewing duodenoscope. We hypothesize significant gastrointestinal findings are missed due to the side-viewing design of the duodenoscope and that at least a subset of patients would benefit from concomitant forward-viewing exam (i.e…
Roux-en-Y Gastric Bypass (RYGB) is a well-known safe and effective surgical option for weight loss in patients with obesity. However, RYGB has many complications, including gastro-gastric fistula (GGF) formation…
INTRODUCTION: Roux-en-Y gastric bypass (RYGB) is an effective treatment for patients suffering from obesity and concomitant type 2 diabetes mellitus (T2DM). Nevertheless, less than 2% of eligible patients choose to undergo the surgery…
BACKGROUND AND AIMS: The Primary Obesity Surgery Endoluminal 2.0 (POSE2.0) is an endoscopic gastric remodeling procedure that utilizes an incisionless operating platform (IOP, San Clemente, CA) to remodel the stomach and alter appetite (FIGURE 1)…
Metabolic dysfunction-associated steatohepatitis (MASH) is traditionally treated with lifestyle modification. Nevertheless, most patients are unable to achieve the 10% total weight loss (TWL) threshold required for fibrosis regression…
Weight regain following sleeve gastrectomy (SG) is not uncommon. This condition is often treated with surgical re-sleeve (SRS) or conversion to Roux-en-Y gastric bypass (SG-GB), especially for patients with concomitant acid reflux…
BACKGROUND: Benign and malignant gastric outlet obstruction (GOO) at the remnant stomach in patients with Roux-en-Y gastric bypass (RYGB) can potentially be life-threatening…
Basil I. Hirschowitz Endoscopic Center of Excellence, Division of Gastroenterology & Hepatology, Department of Internal Medicine, The University of Alabama at Birmingham Heersink School of Medicine